Discovery of novel trisubstituted cyclohexane derivatives as potent and bioavailable CCR2 antagonists

被引：0

作者：

Cherney, Robert J. ^{[1
]}

Mo, Ruowei ^{[1
]}

Yang, Michael G. ^{[1
]}

Xiao, Zili ^{[1
]}

Meyer, Dayton T. ^{[1
]}

Zhao, Qihong ^{[1
]}

Mandlekar, Sandhya ^{[1
]}

Lo, Yvonne C. ^{[1
]}

Yang, Gengjie ^{[1
]}

Miller, Persymphonie B. ^{[1
]}

Scherle, Peggy A. ^{[1
]}

Wasserman, Zelda R. ^{[1
]}

Jezak, Heather ^{[1
]}

Solomon, Kimberly A. ^{[1
]}

Tebben, Andrew J. ^{[1
]}

Cvijic, Mary Ellen ^{[1
]}

Barrish, Joel C. ^{[1
]}

Decicco, Carl P. ^{[1
]}

Carter, Percy H. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08543 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

292-MEDI

引用

页数：1

共 50 条

[31] Discovery of a novel CCR2 antagonist as development candidate via divergent SARs of CCR2 and hERG
Zhang, Xuqing
Hou, Cuifen
Hufnagel, Heather
Markotan, Thomas
Lanter, James
Cai, Chaozhong
Singer, Monica
Opas, Evan
McKenney, Sandra
Crysler, Carl
Johnson, Dana
Sui, Zhihua
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[32] The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity
Cumming, John G.
Bower, Justin F.
Waterson, David
Faull, Alan
Poyser, Philip J.
Turner, Paul
McDermott, Benjamin
Campbell, Andrew D.
Hudson, Julian
James, Michael
Winter, Jon
Wood, Christine
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3895 - 3899
[33] The discovery of MK-0812, a potent and selective CCR2 antagonist
Yang, Lihu
Jiao, Richard X.
Moyes, Chris
Morriello, Greg
Butora, Gabor
Shankaran, K.
Pasternak, Alexander
Goble, Steve
Zhou, Changyou
MacCoss, Malcolm
Cumiskey, Anne-Marie
Peterson, Larry
Forrest, Mike
Ayala, Julia M.
Jin, Hong
DeMartino, Julie
Mills, Sander G.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 580 - 580
[34] Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists
Xia, Mingde
Hou, Cuifen
Pollack, Scott
Brackley, James
DeMong, Duane
Pan, Meng
Singer, Monica
Matheis, Michele
Olini, Gil
Cavender, Druie
Wachter, Michael
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5964 - 5968
[35] Novel, acidic CCR2 receptor antagonists: Lead optimization
Dasse, O. A.
Evans, J. L.
Zhai, H.-X.
Zou, D.
Kintigh, J. T.
Chan, F.
Hamilton, K.
Hill, E.
Eckman, J. B.
Higgins, P. J.
Volosov, A.
Collart, P.
Nicolas, J.-M.
Kondru, R. K.
Schwartz, C. E.
LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (04) : 263 - 271
[36] Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists
Yang, LH
Zhou, CY
Guo, LQ
Morriello, G
Butora, G
Pasternak, A
Parsons, WH
Mills, SG
MacCoss, M
Vicario, PP
Zweerink, H
Ayala, JM
Goyal, S
Hanlon, WA
Cascieri, MA
Springer, MS
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) : 3735 - 3739
[37] Recent developments in CCR2 antagonists
Xia, Mingde
Sui, Zhihua
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (03) : 295 - 303
[38] Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists
Allen, S
Newhouse, B
Anderson, AS
Fauber, B
Allen, A
Chantry, D
Eberhardt, C
Odingo, J
Burgess, LE
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) : 1619 - 1624
[39] Structure-based discovery of novel indolizines as potent and orally bioavailable Bcl-2 antagonists
Letiran, Arnaud
Le Diguarher, Thierry
Starck, Jerome
Murray, James
Davidson, James
Henlin, Jean
Graham, Christopher
Chen, I-Jen
Geneste, Olivier
Hickman, John
Nyerges, Miklos
De Nanteuil, Guillaume
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[40] Design and synthesis of novel small molecule CCR2 antagonists: Evaluation of 4-aminopiperidine derivatives
Vilums, M.
Zweemer, A. J. M.
Dekkers, S.
Askar, Y.
de Vries, H.
Saunders, J.
Stamos, D.
Brussee, J.
Heitman, L. H.
IJzerman, A. P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (23) : 5377 - 5380

← 1 2 3 4 5 →